Cellebrite DI
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, scrutinize, i...
Latest News
1 day ago · seekingalpha.com
Cellebrite DI: Continuous Innovation Including AI Can Drive GrowthCellebrite DI combines double-digit growth and an attractive valuation, positioning the stock for a potential reversal of its multiyear downtrend. Q3 revenue rose 18% to $149 million and ARR increased 20% to $528.5 million, supported by federal and international demand. CLBT raised 2026 adjusted EBITDA guidance to $163 million–$166 million.
4 days ago · seekingalpha.com
Cellebrite DI Ltd. (CLBT) Q3 2026 Earnings Call TranscriptCellebrite DI Ltd. ( CLBT ) Q3 2026 Earnings Call November 12, 2026 8:30 AM EST Company Participants Andrew Kramer - VP of Investor Relations & Treasury Shiven Ramji - CEO & Director David Barter - Chief Financial Officer Marcus Jewell - Global Chief Revenue Officer Conference Call Participants Shaul Eyal - TD Cowen, Research Division Bhavin Shah - Deutsche Bank AG, Research Division Eric Martinuzzi - Lake Street Capital Markets, LLC, Research Division Jeff Van Rhee - Craig-Hallum Capital Group LLC, Research Division Brian Essex - JPMorgan Chase & Co, Research Division Rudy Kessinger - D.A.
4 days ago · marketbeat.com
Cellebrite DI Q3 Earnings Call HighlightsCellebrite DI NASDAQ: CLBT reported third-quarter revenue and annual recurring revenue growth of 18% and 20%, respectively, as international sales and improving U.S. federal demand helped the digital forensics company exceed its guidance.
4 days ago · zacks.com
Cellebrite DI Ltd. (CLBT) Q3 Earnings Meet EstimatesCellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.17 per share, in line with the Zacks Consensus Estimate.
4 days ago · prnewswire.com
Cellebrite Reports Third-Quarter 2026 ResultsThird-Quarter ARR Growth of 20% and TTM Free Cash Flow Margin of 31% Net income of $26.7 million; Non-GAAP net income of $45.6 million and adjusted EBITDA of $53.6 million, 36% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 12, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
8 days ago · prnewswire.com
Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Nov. 9, 2026 /PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced it will report its third-quarter 2026 financial results before the U.S. markets open on Thursday, November 12, 2026, which is unchanged from its October 20, 2026 announcement.
12 days ago · prnewswire.com
Cellebrite Appoints Rogerio Rizzi Executive Vice President of Corporate Strategy and DevelopmentFormer Okta and SAP strategy leader brings AI, platform and M&A expertise to accelerate Cellebrite's growth TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 5, 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced the appointment of Rogerio Rizzi as executive vice president of Corporate Strategy and Development.
27 days ago · prnewswire.com
Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for InvestigationsInvestigators report dramatic gains in what they uncover using Agentic AI vs. manual review; the Autumn 2026 Release brings expanded device and operating system access TYSONS CORNER, Va.
28 days ago · prnewswire.com
Cellebrite publiera ses résultats financiers du troisième trimestre 2026 le 12 novembre 2026/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), leader mondial des solutions numériques d'investigation et de renseignement basées sur l'IA pour les
1 month ago · newsfilecorp.com
Kaplan Fox is Investigating Cellebrite DI Ltd. (CLBT) for Investors Who Suffered LossesNew York, New York--(Newsfile Corp. - October 6, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove CLBT